Gilgamesh (Seed)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$200,000,017
Company Info
Founders
Jonathan Sporn
Market
Healthcare & Wellness
Coinvestors
Route 66,Prime Movers Lab Fund II LP,Prime Movers Labs,NLX,Satori Venture,Ambria,CTR Capital,Negev Capital,Ayuh Ventures,Noetic Fund,Gron Ventures,PsyMed Ventures,Palo Santo
Company Description

Developer of central nervous system drugs intended to treat neurological disorders. Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.

Links
WebsiteCrunchbaseTwitter
Back to HomeBack to Healthcare and Biotech DealsView Funding Announcement